These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4585727)

  • 21. [MK-130, a new drug for the treatment of muscular hypertonia. Preliminary trial in 10 patients with spasticity of spinal origin].
    Molina-Negro P; Illingworth RA
    Union Med Can; 1971 Oct; 100(10):1947-51. PubMed ID: 5142212
    [No Abstract]   [Full Text] [Related]  

  • 22. [C34.647-Ba (Lioresal) in the treatment of hypertonic manifestations of multiple sclerosis].
    Ketelaer P; Tyberghein JM; Ketelaer CJ
    Brux Med; 1973 Nov; 53(11):675-81. PubMed ID: 4769203
    [No Abstract]   [Full Text] [Related]  

  • 23. [Etiology and treatment of muscle spasm phenomena. Study on muscle-tonolytic effect of CIBA 34'647 Ba].
    Aebert K
    Med Welt; 1972 Sep; 23(36):1224-7. PubMed ID: 4562536
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on spasticity. I. Diazepam in the treatment of spasticity. Considerations on its management in clinical practice and neurological rehabilitation].
    Giménez Roldán S; Martínez Fuertes L; Avila J
    Rev Clin Esp; 1969 Nov; 115(3):197-208. PubMed ID: 5405432
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of flexor spasms with Lioresal.
    Shahani BT; Young RR
    Arch Phys Med Rehabil; 1974 Oct; 55(10):465-7. PubMed ID: 4153400
    [No Abstract]   [Full Text] [Related]  

  • 26. Baclofen and carbamazepine in supraspinal spasticity.
    Fodstad H; Ljunggren BC
    J R Soc Med; 1991 Dec; 84(12):747-8. PubMed ID: 1663553
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of lioresal on the rehabilitation of spastics].
    Gusta A; Matwiejko L; Pienc A
    Chir Narzadow Ruchu Ortop Pol; 1977; 42(2):193-7. PubMed ID: 891318
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug therapy of spinal spasms].
    Paeslack V
    Verh Dtsch Ges Inn Med; 1965; 71():665-7. PubMed ID: 5877681
    [No Abstract]   [Full Text] [Related]  

  • 29. Dosage of intrathecal baclofen maintenance therapy in the spastic syndromes.
    Fares Y; Khazim RM; del Barrio ER; Burzaco JA
    J Med Liban; 2004; 52(1):13-8. PubMed ID: 15881696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study.
    Basmajian JV; Yucel V
    Am J Phys Med; 1974 Oct; 53(5):223-8. PubMed ID: 4153338
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intrathecal baclofen for severe spasticity].
    Ueta T
    Brain Nerve; 2008 Dec; 60(12):1415-20. PubMed ID: 19110752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of spasticity with dantrolene sodium].
    Winnem M
    Tidsskr Nor Laegeforen; 1980 Oct; 100(29):1727-8. PubMed ID: 7008246
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of Beclofen in spastic cases].
    Manelis J
    Harefuah; 1975 Dec; 89(12):569-70. PubMed ID: 1218838
    [No Abstract]   [Full Text] [Related]  

  • 34. The antispastic effects of Ba 34647 (B-4-p-chlorophenyl-gamma-amino-butyric acid) a GABA derivative.
    Lapierre YD; Elie R; Tetreault L
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1059-68. PubMed ID: 4154825
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fenoxedil in cerebral and spinal cord circulatory insufficiency].
    Lehembre P; Warot P
    Lille Med; 1976 Jan; 21(1 suppl 1):1-3. PubMed ID: 1256224
    [No Abstract]   [Full Text] [Related]  

  • 36. Spasticity.
    Melia D
    Prof Nurse; 1998 Sep; 13(12):858-61. PubMed ID: 10095681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of beta-(p-clorophenil)-gamma-aminobutirric acid in the treatment of hemiplegic patients with hypertonius (author's transl)].
    Prati R; Soriani S
    Riv Patol Nerv Ment; 1974 Oct; 95(5):651-2. PubMed ID: 4470264
    [No Abstract]   [Full Text] [Related]  

  • 38. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
    Gracies JM; Nance P; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S92-120. PubMed ID: 9826984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baclofen in the treatment of spasticity.
    Hudgson P; Weightman D
    Br Med J; 1971 Oct; 4(5778):15-7. PubMed ID: 4938243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 66A-078:a kappa-opiate receptor agonist for amelioration of spinal spasticity.
    Yuan Y; Yan SC; Chen XH; Han JS
    Chin Med J (Engl); 1994 Mar; 107(3):192-5. PubMed ID: 7916279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.